Stock Snapshot for NYSE: BDX

About BD

BD is a global medical technology company that is advancing the world of healthTM by improving medical discovery, diagnostics and the delivery of care.

70,000+

BD Associates

190+

Countries Served

34B+

Devices Made Annually

$1B+

Annual R&D Spending

33,000+

Active Patents

As of Jan 24, 2023 • Annual Meeting of Shareholders Presentation

For complete information regarding our financials, see our periodic filings

Latest Financial Results

$5.2B

Q1 2025 Total BD Revenue

$3.43

Q1 2025 Adjusted EPS*

Source: Q1 2025 Earning Press Release
* Non-GAAP Financial Measures. View full reconciliation in our Q1 earnings press release.

For complete information regarding our financials, see our periodic filings

Latest Annual Filing

For Fiscal Year Ending Sep 30, 2024

Latest News

BD to Present at Investor Healthcare Conferences

View Press Release

BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value

View Press Release

BD Reports First Quarter Fiscal 2025 Financial Results

View Press Release

See How BD Solutions Advance Care Across The Patient Journey

Learn More

Together We Advance

Our Corporate Sustainability strategy—a four-pillar framework called Together We Advance—embraces the connections and interdependence between company health, planet health, community health and human health. Through this framework, we address the most relevant Corporate Sustainability issues for our business and stakeholders.

View Corporate Sustainability Efforts

Featured Reports

2024 Annual Report

2024 Annual Report

Download Report
2023 Sustainability Report

2023 Sustainability Report

Download Report
2022 Inclusion, Diversity and Equity Report

2022 Inclusion, Diversity and Equity Report

Download Report
2022 Cybersecurity Annual Report

2022 Cybersecurity Annual Report

Download Report

IR Contacts

Corporate Office

Becton, Dickinson and Company
1 Becton Drive
Franklin Lakes, NJ 07417
United States
800.284.6845

Investor Relations

Becton, Dickinson and Company
800.284.6845
investor_relations@bd.com

Transfer Agent

Computershare Trust Company, N.A.
P.O. Box 43006
Providence, RI 02940-3066
877.498.8861
computershare@computershare.com
https://www.computershare.com


Overnight Mail Address
150 Royall St., Suite 101
Canton, MA 02021